Yield Theory

Congressional trades by ticker

REGN congressional trades

Regeneron Pharmaceuticals, Inc. appears in 13 verified House Clerk rows from Byron Donalds, Gilbert Cisneros, Jefferson Shreve, Josh Gottheimer, and 3 other members across the 2025–2026 periodic reports. The table keeps disclosed owners and amount ranges; it is not a live REGN portfolio.
Verified rows
13
Filers
7
Purchases
4
Latest trade
2026-05-15

Verified REGN House disclosures

Parsed from official House Clerk periodic transaction reports. This snapshot contains 4 purchases and 9 sales. Reported owners: Self, Spouse, Joint. Transaction dates run from 2025-01-15 to 2026-05-15.

PoliticianTrade dateAssetTypeOwnerAmountFiling
Gilbert CisnerosRegeneron Pharmaceuticals, Inc. - Common StockSaleSelf$1,001 - $15,000#20034713
Filed 2026-06-08
Julia LetlowRegeneron Pharmaceuticals, Inc. - Common StockPurchaseSelf$1,001 - $15,000#20034106
Filed 2026-03-12
Gilbert CisnerosRegeneron Pharmaceuticals, Inc. - Common StockPurchaseSelf$1,001 - $15,000#20033619
Filed 2025-12-15
Robert BresnahanRegeneron Pharmaceuticals, Inc. - Common StockPurchaseSelf$1,001 - $15,000#20030482
Filed 2025-06-09
Byron DonaldsRegeneron Pharmaceuticals, Inc. - Common StockSaleSelf$1,001 - $15,000#20030342
Filed 2025-05-24
Byron DonaldsRegeneron Pharmaceuticals, Inc. - Common StockSaleSpouse$1,001 - $15,000#20030342
Filed 2025-05-24
Robert BresnahanRegeneron Pharmaceuticals, Inc. - Common StockSaleSelf$1,001 - $15,000#20030291
Filed 2025-05-08
Jefferson ShreveRegeneron Pharmaceuticals, Inc. - Common StockSaleSelf$15,001 - $50,000#20030231
Filed 2025-05-08
Julie JohnsonRegeneron Pharmaceuticals, Inc. - Common StockSaleJoint$1,001 - $15,000#20030296
Filed 2025-05-14
Robert BresnahanRegeneron Pharmaceuticals, Inc. - Common StockSaleSelf$1,001 - $15,000#20029034
Filed 2025-03-27
Julie JohnsonRegeneron Pharmaceuticals, Inc. - Common StockSaleJoint$1,001 - $15,000#20027936
Filed 2025-03-12
Josh GottheimerRegeneron Pharmaceuticals, Inc. - Common StockSaleJoint$1,001 - $15,000#20026732
Filed 2025-02-10
Julie JohnsonRegeneron Pharmaceuticals, Inc. - Common StockPurchaseJoint$1,001 - $15,000#20026762
Filed 2025-02-12

A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.

The filing is free

Keep the REGN range and owner as filed. Membership adds the investment view around the money, not a list to copy.

Get this month’s call for $15

REGN congressional trades — FAQ

Who in Congress traded REGN?

House Clerk periodic reports for 2025 and 2026 contain 13 verified REGN rows from 7 members: Byron Donalds, Gilbert Cisneros, Jefferson Shreve, Josh Gottheimer, and 3 other members. Image-only filings are excluded, and this is not a live brokerage statement.

Does this page show current REGN holdings?

No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.

Why are REGN amounts shown as ranges?

House periodic transaction reports use statutory value bands such as $1,001 - $15,000; $15,001 - $50,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.

How complete is REGN congressional-trade coverage?

This snapshot covers every machine-readable House periodic transaction report for 2025 and 2026 (142 members). Image-only filings and Senate eFD filings are not included, so missing rows are not proof that no other lawmaker traded REGN.

Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk periodic report snapshot generated 2026-09-20. It is not a complete lifetime portfolio, a performance track record, or investment advice.

A disclosure is not a thesis.

This page shows who reported REGN and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $15/month or $150/year.

$15/mo or $150/yr · cancel future renewals anytime · sources included